Filana Therapeutics, Inc. (FLNA)
0.8639
+0.01
(+0.77%)
USD |
NASDAQ |
Sep 02, 16:00
0.8639
0.00 (0.00%)
After-Hours: 19:31
Filana Therapeutics Cash from Operations (Annual) : -32.25M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -32.25M |
| December 31, 2024 | -116.93M |
| December 31, 2023 | -82.02M |
| December 31, 2022 | -77.51M |
| December 31, 2021 | -30.20M |
| December 31, 2020 | -5.382M |
| December 31, 2019 | -2.514M |
| December 31, 2018 | -4.77M |
| December 31, 2017 | -8.237M |
| December 31, 2016 | -12.23M |
| December 31, 2015 | -9.053M |
| December 31, 2014 | -9.549M |
| December 31, 2013 | -6.947M |
| December 31, 2012 | -7.171M |
| Date | Value |
|---|---|
| December 31, 2011 | -0.26M |
| December 31, 2010 | -0.143M |
| December 31, 2009 | -14.69M |
| December 31, 2008 | 11.16M |
| December 31, 2007 | 2.231M |
| December 31, 2006 | -11.83M |
| December 31, 2005 | 113.23M |
| December 31, 2004 | -32.57M |
| December 31, 2003 | -20.51M |
| December 31, 2002 | -15.50M |
| December 31, 2001 | -12.37M |
| December 31, 2000 | -7.385M |
| December 31, 1999 | -2.694M |
| December 31, 1998 | -0.319M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| CorMedix, Inc. | 175.05M |
| Eloxx Pharmaceuticals, Inc. | -6.327M |
| Cannabis Global, Inc. | -0.2899M |
| Breakthrough Chemistry, Inc. | -0.0131M |
| BioStem Technologies, Inc. | 9.941M |